Tanya J Major1, James Boocock1, Asim Mandal6, Murray Cadzow1, Ruth K Topless1, Amanda J Phipps-Green1, Nicola Dalbeth2, Lisa K Stamp3, David B Mount4, Hyon K Choi5, Eli A Stahl6, Tony R Merriman1
Study of urate transporters in primary hyperuricemia and gout
Blanka Stiburkova1,3, Katerina Pavelcova1,2, Lenka Petru1,2, Jakub Zavada1 and Karel Pavelka1
Félix Renaudin1, Laure Campillo-Gimenez 1, Christèle Combes2, Marjolaine Gosset3, Martine Cohen-Solal1,4, Frédéric Lioté1,4, Hang-Korng Ea1,4
Tania O. Crișan 1,2, Maartje C.P. Cleophas1, Rob ter Horst1, Inge van de Munckhof1, Joost Rutten1, Tim L. Jansen3, Niels Riksen1, Charles Dinarello1,4, Mihai G. Netea1, Leo A.B. Joosten1,2
Gout at the spine :
a retrospective study with dual-energy computed tomography
E. Chotard 1, J. M. Sverzut 2 , F. Lioté 1, 3, T. Bardin 1, 3, H.K. Ea 1, 3
Laure Campillo-Gimenez1, Pierre Gras2, Christèle Combes2, Martine Cohen-Solal1,3, Frédéric Lioté1,3, Hang-Korng Ea1,3.
Inhibition of class I histone deacetylases as novel therapeutic option in gouty arthritis.
Maartje C.P. Cleophas 1, Tania O. Crişan 1, Charles A. Dinarello 1, 2, Mihai G. Netea 1, Leo A.B. Joosten 1.
Soluble urate primes inflammatory responses via activation of the Akt-PRAS40-mTOR pathway.
Tania O. Crișan1, Maartje C.P. Cleophas1, Kathrin Buffen1, Tim L. Jansen2, Charles Dinarello1,3, Mihai G. Netea1, Leo A.B. Joosten1
Q. Ma1, R. Immler ², M. Pruenster ², M. Honarpisheh ¹, M. Lindenmeyer 1,3, M. Sellmayr ¹, C. Böhland 4, M. Sperandio ², HJ. Anders ¹ & S. Steiger ¹.
The impact of dysfunctional variants of abcg2 on hyperuricemia and gout in pediatric-onset patients
B. Stiburkova 1,3, K. Pavelcova 1,2, M. Pavlikova 1, P. Ješina 3, K. Pavelka 1
I. Hotea 1, T. O. Crisan 2, C. Pamfil 1, M. Badii 2, O. Gall 2, L. Peca², A. Mirea², R. Popp 2, S. Rednic 1,3, L. Ab Joosten 2,4.
Ultrasound features of synovitis in patients with osteoarthritis
R. Shumnalieva, R. Gancheva, S. Monov
The role of igf-1r in urate induced inflammation
O. Gaal ¹, M. Badii 1, G. Cabau 1, T. O. Crișan 1, M. F. Farcaș 1, I. Hotea 2, C. Pamfil 2, S. Rednic 2, R. A. Popp 1, L.a.b. Joosten 1,3, Hint Consortium
Involvement of socs3 regulation in urate-induced proinflammatory effects
M. Badii ¹, O. Gaal ¹, V. Kluck ², G. Cabau ¹, L. Peca ¹, C. G. Andra ¹, R. Popp ¹, T. Octavia Crișan ¹, L. A. B. Joosten ¹,2 and the Hint Consortium
Polynesian specific gout associated missense variants in lrp2
M. Leask 1, T. Fatima 1, A. Jones 1, M. Cadzow 1, N. Dalbeth 5, L. Stamp 7, J. H. Hindmarsh 6, D. Mount 3, E. Stahl 2, H. Choi 4 and T. Merriman 1
M. H. Pillinger, S. Wang, S. Krasnokutsky, K. Barbour
CONTRIBUTION OF MOCS ON XANTHINURIA TYPE III, AND ITS CLINICAL SIGNIFICANCE FOR SCREENING
C. Sungkweon 1, C. A. Winkler 2, B. Stiburkova 3,4
R. Gancheva 1, T. Velikova 2, T. Kundurzhiev 3, Z. Kolarov 1, A. Koundurdjiev 4
ALLELIC VARIANTS OF URATE TRANSPORTOSOME IN PRIMARY HYPERURICEMIA AND GOUT
B. Stiburkova 1,3, K. Pavelcova 1,2, J. Bohata 1,2, M. Pavlikova 4, Y. Toyoda 5, T. Takada 5, H. Suzuki 5, L. Petru 1,2, J. Zavada 1, K. Pavelka 1
A PUTATIVE ROLE OF IGF-1R IN THE PATHOGENESIS OF GOUT THROUGH TRANSCRIPTION FACTOR
R. Liu 1, O. Gaal 3, V. Klück 1, T. O. Crișan 3, S. Fanucchi 4, M. Mhlanga 4, L. Joosten 1, 2, 3